Skip to Content
FTC To Hold Open Meeting To Consider Key Policy Statement on Improper Patent Listings
Big Pharma Exploits FDA’s “Orange Book” to Prevent the Entry of Lower-Cost Generics and Block Competition
Text of Letter (PDF)
Washington, D.C. – U.S. Representative Pramila…
Issues:
Health Care,
Science, Technology, & Antitrust
Progressive leaders in Senate and House demand answers from AI CEOs as they’re set to appear in Congress for special briefing
Lawmakers: “Tech companies must not build AI on the backs of exploited workers.”
Text of Letter (PDF)
Washington (September…
Issues:
Jobs, Labor, & the Economy,
Science, Technology, & Antitrust
Washington, D.C. – US. Representative Pramila Jayapal (D-Wash.) and Senator Elizabeth Warren (D-Mass.) sent a letter to Dr. Robert M. Califf, Commissioner of the Food and Drug Administration (FDA), urging him to close loopholes that pharmaceutical companies have exploited to block…
Issues:
Health Care,
Science, Technology, & Antitrust
Text of Letter (PDF)
Washington (June 22, 2023) – Representative Pramila Jayapal (WA-07) and Senator Edward J. Markey (D-Mass.), a member of the Senate Commerce, Science, and Transportation Committee, led 15 of their colleagues in writing to Federal Trade Commission…
Issues:
Government Reform & Ethics,
Science, Technology, & Antitrust
Washington, D.C. – U.S. Representative Pramila Jayapal (D-Wash.) and U.S. Senator Elizabeth Warren (D-Mass.) sent a letter to Kathi Vidal, Director of the United States Patent and Trademark Office (USPTO), calling on USPTO to take immediate action and use its…
Issues:
Health Care,
Science, Technology, & Antitrust
WASHINGTON – U.S. Representatives Pramila Jayapal (WA-07) and Victoria Spartz (IN-05) are introducing bipartisan legislation to stop anticompetitive hospital conduct, which has been shown to lead to higher costs for patients and restricted care. The Stop Anticompetitive Healthcare Act would…
Issues:
Health Care,
Science, Technology, & Antitrust
